Patents / Automotive
Ford fuel-injection patent win survives Ethanol Boosting appeal
A late-December Federal Circuit opinion kept focus on claim construction, prior IPR history, and engine-control patents.
Patents / Automotive
A late-December Federal Circuit opinion kept focus on claim construction, prior IPR history, and engine-control patents.
Patents / Automotive
A late-December Federal Circuit opinion kept focus on claim construction, prior IPR history, and engine-control patents.
Policy / PTAB Policy
Trade Secrets / Trade Secrets
Patents / IPR
Policy / PTAB Policy
A Federal Circuit order left Motorola without extraordinary relief after the Acting Director ended IPRs in view of parallel district-court litigation.
Trade Secrets / Anti-SLAPP
The Federal Circuit held that IQE's pleaded misappropriation theory arose from Tower's filing of patent applications.
Patents / IPR
The Federal Circuit held that a PTAB loss on parent claims did not automatically preclude dependent claims the Board had not found unpatentable.
Policy / PTAB Policy
The Federal Circuit held that claimed future harms from IPR and PGR institution policy were too speculative to support Article III jurisdiction.
Patents / Damages
The Federal Circuit reviewed expert damages proof in a medical-device patent case involving Intuitive Surgical stapler products.
Patents / Consumer Products
The Federal Circuit reviewed a consumer-product case involving patent and trade-dress theories around embedded-ring shower curtains.
Patents / Hatch-Waxman
The Federal Circuit reviewed treatment claims involving rivaroxaban and aspirin for reducing cardiovascular-event risk.
Patents / Prosecution
The Federal Circuit faulted the Board's categorical Section 101 treatment of apparatus and system claims.
Patents / Prosecution
The Federal Circuit affirmed PTO wins involving Gilbert Hyatt's older patent applications and Article III limits on pending claims.
Patents / Section 101
The Federal Circuit held that claims directed to a compact adjustable dumbbell were not abstract at Alice step one.
Patents / Energy
The Federal Circuit reviewed PTAB treatment of module-level solar technology claims and implicit claim construction.
Patents / IPR
A Federal Circuit order continued the long-running rewards-program patent dispute after earlier PTAB and estoppel rulings.
Patents / Gaming
The Federal Circuit reviewed a casino-gaming patent dispute involving older interference activity and Zynga's later IPR petition.
Patents / Medical Devices
The Federal Circuit reviewed PTAB findings on a medical-device patent directed to treating calcified vascular lesions.
Patents / Hatch-Waxman
The Federal Circuit reviewed obviousness and written-description issues in a Hatch-Waxman fight over paliperidone palmitate treatment claims.
Patents / IPR
The Federal Circuit reviewed claim-scope findings and prior-art mapping in an IPR over website-generation technology.
Patents / SEP
The Federal Circuit reviewed a large Texas verdict record involving cellular standards patents and multiple validity and evidentiary issues.
Patents / Software
The Federal Circuit affirmed PTAB treatment of a security-patent term in an IPR involving Roku and Nintendo.
Patents / Section 101
The Federal Circuit held that claims using OCR in remote check deposit were patent-ineligible on summary judgment.
Patents / Biotech
The Federal Circuit reviewed PTAB final written decisions in related IPRs over CRISPR guide-RNA technology.
Patents / IPR
The Federal Circuit reiterated that IPR participation alone does not create appellate standing.
Patents / Mobile
The Federal Circuit reviewed Apple's PTAB appeal involving a Gesture Technology patent and mobile-camera interaction claims.
Patents / Damages
The Federal Circuit remanded a smart-thermostat damages case in one of 2025's most important patent opinions.
Patents / Mobile
The Federal Circuit reviewed PTAB findings over whether prior art disclosed a disputed user-action limitation.
Patents / Prosecution
The Federal Circuit reviewed a Board affirmance involving anticipation and an applicant affidavit.
Patents / IPR
The Federal Circuit addressed jury instructions, prior-art use at trial, and the scope of IPR estoppel.
Patents / Hatch-Waxman
The Federal Circuit rejected the idea that a regulatory filing alone can create the artificial infringement needed for a Hatch-Waxman suit.
Patents / Section 101
The Federal Circuit affirmed Section 101 invalidity in a dispute involving display and device-control patent claims.
Patents / IPR
The Federal Circuit revisited when admitted prior art may be used in an IPR obviousness analysis without becoming the statutory basis of the ground.
Patents / AI
The Federal Circuit held that using generic machine learning for TV network maps and live-event schedules did not supply patent-eligible subject matter.
Patents / Prosecution
The Federal Circuit affirmed a PTO decision after applying substantial-evidence review to anticipation findings.
Patents / Hatch-Waxman
The Federal Circuit emphasized that district courts decide patent issues while FDA decides safety, effectiveness, and bioequivalence.
Patents / Biotech
The Federal Circuit reviewed formulation claim language in a biologics-adjacent dispute over VEGF antagonist treatment technology.
Patents / Hatch-Waxman
The Federal Circuit addressed how patent term extensions apply when a reissued patent sits in the regulatory-review timeline.
Patents / ITC
The Federal Circuit clarified how an American company can satisfy Section 337's domestic-industry requirement for products manufactured abroad.
Patents / IPR
The Federal Circuit affirmed unpatentability findings for selected claims in Gesture's image-capture patent.
Patents / IPR
The Federal Circuit affirmed an IPR decision involving LED technology and whether a reference qualified as prior art.
Patents / Hatch-Waxman
The Federal Circuit held that a later-filed, later-issued, earlier-expiring family member was not a proper ODP reference against Allergan's earlier patent.
Patents / Damages
The Federal Circuit's 2024 panel decision in the Nest thermostat dispute became the platform for the court's later en banc damages review.
Policy / Design Patents
The agency instructed design examiners and PTAB panels to apply LKQ's more flexible obviousness framework.
Patents / Design Patents
The en banc court abandoned the Rosen-Durling framework and moved design patents toward Graham and KSR.
Patents / Prosecution
The Federal Circuit held that ODP analysis for PTA-extended patents looks to the expiration date after PTA is added.
Patents / IPR
The court said the Board had to consider petitioner arguments responding to a claim construction first raised by the patent owner.
Trademarks / Supreme Court
The Court rejected a worldwide damages theory and focused the Lanham Act inquiry on domestic use in commerce.
Trademarks / Supreme Court
The Court held that VIP could not automatically invoke Rogers when it used Jack Daniel's marks as source identifiers on a dog toy.
Patents / Biotech
The Court held that Amgen had not enabled the full scope of functional antibody claims covering PCSK9 binding.
Copyright / Fair Use
The Supreme Court held that the licensing use of a Warhol Prince image weighed against fair use in the dispute with photographer Lynn Goldsmith.
Patents / AI
Thaler v. Vidal held that inventors must be natural persons, keeping DABUS out of U.S. patent inventorship.
Patents / Section 101
The Court declined to review a Federal Circuit Section 101 decision involving automotive driveshaft manufacturing claims.
Copyright / Supreme Court
The Court held that lack of legal or factual knowledge can excuse inaccurate registration information under Section 411(b).
Patents / Supreme Court
The Supreme Court kept assignor estoppel alive but limited it to invalidity arguments inconsistent with the assignor's representations.
Policy / PTAB Policy
The Supreme Court held that APJ authority required a path for review by the presidentially appointed PTO Director.
Copyright / Software
The Court held that Google's reuse of Java API declaring code in Android was fair use.
Trademarks / Supreme Court
The Court held that a generic.com term is not automatically generic if consumers perceive it as a source identifier.
Trademarks / Supreme Court
The Court held that Marcel could not block Lucky Brand's release defense when the later suit involved different claims.
Copyright / Supreme Court
The Supreme Court held that official annotations prepared under legislative authority could not be copyrighted.
Trademarks / Supreme Court
The Supreme Court held that willfulness is not an absolute prerequisite to disgorgement of profits under the Lanham Act.
Patents / IPR
The Supreme Court held that Section 314(d) bars appeal of the PTAB's decision to institute IPR despite a Section 315(b) time-bar argument.